The Food and Drug Administration posted documents Wednesday finding a single-dose COVID-19 vaccine developed by Johnson & Johnson had a “favorable safety profile with no specific concerns identified that would preclude issuance of an EUA.”
25
Feb
The Food and Drug Administration posted documents Wednesday finding a single-dose COVID-19 vaccine developed by Johnson & Johnson had a “favorable safety profile with no specific concerns identified that would preclude issuance of an EUA.”